Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Herantis Pharma - Invitation to 1H 2022 Report on August 25, 2022.

Document Cited in Related
Vincent

ENPNewswire-August 5, 2022--Herantis Pharma - Invitation to 1H 2022 Report on August 25, 2022

(C)2022 ENPublishing - http://www.enpublishing.co.uk

Release date- 04082022 - Herantis Pharma Plc('Herantis') an innovative biotech company developing new disease modifying therapies for Parkinson's disease, announced that it will release 1H 2022 Report on Thursday August 25, 2022, at 08:00 EEST/ 07:00 CEST.

Members of the Herantis' Management team will hold a live webinar to provide more details on the 1H 2022 Report with a live Q&A session (in English) for investors, analysts, and media at 10:00 EEST / 9:00 CEST.

Registration details:

Date: Thursday, August 25, 2022

Time: 10:00 EEST / 9:00 CEST

Link to Registration: Herantis' 1H 2022 Report Webinar

After registering, you will receive a confirmation email containing information about joining the webinar.

Contact:

Julie Silber

Tel: +46 (0)7 93 486 277

Gabriela Urquilla

T: +46 (0)72-396 72 19

Email: ir@herantis.com

Certified Advisor

UB Securities Ltd

Finland

T: +358 9 25 380 225

Sweden

T: +358 40 5161400

Website: www.herantis.com

About Herantis Pharma Plc

Herantis Pharma Plc is an innovative biotech company developing disease modifying therapies for Parkinson's disease. Herantis lead product HER-096, is an advanced...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT